Cite
HARVARD Citation
Huang, V. et al. (n.d.). Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy. Inflammatory bowel diseases. 21 (6), p. . [Online].